1. Author index. (12th November 2019) Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. M10 Persistence on antifibrotic medication in idiopathic pulmonary fibrosis (IPF) is not dependent on distance travelled to tertiary centre. (12th November 2019) Authors: Babu, A; McLellan, T; Verghese, P; Harris, E; Harding, K; Simler, N; Fiddler, C; Parfrey, H; Woodhead, F; Thillai, M Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. M11 Nintedanib and pirfenidone for idiopathic pulmonary fibrosis (IPF) in north east england – real life data. (12th November 2019) Authors: Murphy, CJ; Donaldson, C; Langlands, L; Wiscombe, S; Simpson, AJ; Forrest, IA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. M12 52 month follow up of patients with IPF receiving nintedanib via the compassionate use programme. (12th November 2019) Authors: Ward, K; Ind, P; Woods, D; Springett, J; Dos Santos, C; Hunt, C; Coker, R Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. M13 From interstitial lung disease (ILD) multidisciplinary team meeting (MDT) to anti-fibrotic medication – review of regional MDT referrals. (12th November 2019) Authors: Murphy, CJ; Donaldson, C; Langlands, L; Wiscombe, S; Simpson, AJ; Forrest, IA Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. M14 Has antifibrotic therapy altered outcomes in patients with idiopathic pulmonary fibrosis? A real world analysis. (12th November 2019) Authors: Wright, WA; Nightingale, P; Dosanjh, D; Crawshaw, A; Thickett, DR Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. M15 Antifibrotic medications for idiopathic pulmonary fibrosis (IPF): a real world single centre experience of 447 patients over a 6 year period. (12th November 2019) Authors: Harris, E; Harding, K; McLellan, T; Babu, A; Verghese, P; Parfrey, H; Simler, N; Fiddler, C; Thillai, M Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. M16 Blood and sputum eosinophils, interleukin 5 and bronchiectasis. (12th November 2019) Authors: Chew, V; Davidson, R; Davison, J; Jiwa, K; Davies, G; Jones, G; De Soyza, A Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. M17 Investigating indoleamine 2, 3 dioxygenase (IDO) activity in bronchiectasis and COPD. (12th November 2019) Authors: Potter, R; Huan, L; De Soyza, A; Mellor, A Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. M18 Heparin-binding protein as a biomarker inflammation, symptoms and severity in bronchiectasis. (12th November 2019) Authors: Abo-Leyah, H; Keir, HR; Shoemark, A; Finch, S; Smith, A; Barclay, H; Chalmers, JD Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗